These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36691982)

  • 1. Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome.
    Boktor JC; Sharon G; Verhagen Metman LA; Hall DA; Engen PA; Zreloff Z; Hakim DJ; Bostick JW; Ousey J; Lange D; Humphrey G; Ackermann G; Carlin M; Knight R; Keshavarzian A; Mazmanian SK
    Mov Disord; 2023 Mar; 38(3):399-409. PubMed ID: 36691982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
    Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
    Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease.
    Qian Y; Yang X; Xu S; Huang P; Li B; Du J; He Y; Su B; Xu LM; Wang L; Huang R; Chen S; Xiao Q
    Brain; 2020 Aug; 143(8):2474-2489. PubMed ID: 32844199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
    Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
    Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's Disease and the Gut Microbiome in Rural California.
    Zhang K; Paul KC; Jacobs JP; Chou HL; Duarte Folle A; Del Rosario I; Yu Y; Bronstein JM; Keener AM; Ritz B
    J Parkinsons Dis; 2022; 12(8):2441-2452. PubMed ID: 36442206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
    Bedarf JR; Hildebrand F; Coelho LP; Sunagawa S; Bahram M; Goeser F; Bork P; Wüllner U
    Genome Med; 2017 Apr; 9(1):39. PubMed ID: 28449715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms.
    Wallen ZD; Demirkan A; Twa G; Cohen G; Dean MN; Standaert DG; Sampson TR; Payami H
    Nat Commun; 2022 Nov; 13(1):6958. PubMed ID: 36376318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Sectional Study on the Gut Microbiome of Parkinson's Disease Patients in Central China.
    Mao L; Zhang Y; Tian J; Sang M; Zhang G; Zhou Y; Wang P
    Front Microbiol; 2021; 12():728479. PubMed ID: 34650532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease.
    Rosario D; Bidkhori G; Lee S; Bedarf J; Hildebrand F; Le Chatelier E; Uhlen M; Ehrlich SD; Proctor G; Wüllner U; Mardinoglu A; Shoaie S
    Cell Rep; 2021 Mar; 34(9):108807. PubMed ID: 33657381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes.
    Palacios N; Wilkinson J; Bjornevik K; Schwarzschild MA; McIver L; Ascherio A; Huttenhower C
    Ann Neurol; 2023 Sep; 94(3):486-501. PubMed ID: 37314861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional dynamics of bacterial species in the mouse gut microbiome revealed by metagenomic and metatranscriptomic analyses.
    Chung YW; Gwak HJ; Moon S; Rho M; Ryu JH
    PLoS One; 2020; 15(1):e0227886. PubMed ID: 31978162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis.
    Gupta VK; Cunningham KY; Hur B; Bakshi U; Huang H; Warrington KJ; Taneja V; Myasoedova E; Davis JM; Sung J
    Genome Med; 2021 Sep; 13(1):149. PubMed ID: 34517888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-Analysis of Gut Dysbiosis in Parkinson's Disease.
    Nishiwaki H; Ito M; Ishida T; Hamaguchi T; Maeda T; Kashihara K; Tsuboi Y; Ueyama J; Shimamura T; Mori H; Kurokawa K; Katsuno M; Hirayama M; Ohno K
    Mov Disord; 2020 Sep; 35(9):1626-1635. PubMed ID: 32557853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The gut microbiome in Parkinson's disease].
    Bedarf JR; Hildebrand F; Goeser F; Bork P; Wüllner U
    Nervenarzt; 2019 Feb; 90(2):160-166. PubMed ID: 30171304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxonomic and metabolic development of the human gut microbiome across life stages: a worldwide metagenomic investigation.
    Mancabelli L; Milani C; De Biase R; Bocchio F; Fontana F; Lugli GA; Alessandri G; Tarracchini C; Viappiani A; De Conto F; Nouvenne A; Ticinesi A; Bussolati O; Meschi T; Cecchi R; Turroni F; Ventura M
    mSystems; 2024 Apr; 9(4):e0129423. PubMed ID: 38441032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson's disease.
    Yu J; Meng J; Qin Z; Yu Y; Liang Y; Wang Y; Min D
    J Neuroinflammation; 2023 May; 20(1):117. PubMed ID: 37208728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms.
    Xie A; Ensink E; Li P; Gordevičius J; Marshall LL; George S; Pospisilik JA; Aho VTE; Houser MC; Pereira PAB; Rudi K; Paulin L; Tansey MG; Auvinen P; Brundin P; Brundin L; Labrie V; Scheperjans F
    Mov Disord; 2022 Aug; 37(8):1644-1653. PubMed ID: 35723531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
    Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
    Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metagenome-assembled microbial genomes from Parkinson's disease fecal samples.
    Duru IC; Lecomte A; Shishido TK; Laine P; Suppula J; Paulin L; Scheperjans F; Pereira PAB; Auvinen P
    Sci Rep; 2024 Aug; 14(1):18906. PubMed ID: 39143178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease.
    Chen SJ; Chen CC; Liao HY; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    J Parkinsons Dis; 2022; 12(4):1219-1230. PubMed ID: 35342048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.